Literature DB >> 15760921

Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis.

N Proulx1, D Fréchette, B Toye, J Chan, S Kravcik.   

Abstract

BACKGROUND: Bacterial meningitis continues to cause high mortality. Few studies address the possible association between this mortality and antibiotic administration delays. AIM: To determine whether delays in antibiotic administration are associated with mortality from bacterial meningitis, and to identify inappropriate diagnostic-treatment sequences leading to such delays.
DESIGN: Retrospective case record study.
METHODS: We reviewed 123 cases of adult acute bacterial meningitis in 119 patients aged >/=16 years admitted to hospital from January 1990 to March 2002, using multivariate regression analysis to assess the association between meningitis mortality and door-to-antibiotic time (the time elapsed between emergency room presentation and antibiotics administration).
RESULTS: The case fatality rate was 13% (16/123). Adjusted odds ratios (OR) for mortality were: 8.4 (95%CI 1.7-40.9) for door-to-antibiotic time >6 h; 39.4 (95%CI 4.3-358.1) for afebrility at presentation; and 12.6 (95%CI 2.2-72.0) for severely impaired mental status at presentation. Factors associated with a door-to-antibiotic time of >6 h were: (i) failure to administer antibiotics prior to transfer from another institution (OR 21.8); (ii) the diagnostic-treatment sequence: head CT then lumbar puncture, then antibiotics (OR 5.6); and (iii) the absence of the classic meningitis triad (OR 4.9). DISCUSSION: There is an independent incremental association between delays in administrating antibiotics and mortality from adult acute bacterial meningitis. Inappropriate diagnostic-treatment sequences were significant predictors of such treatment delays.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760921     DOI: 10.1093/qjmed/hci047

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  88 in total

1.  'One for all' concerns regarding NICE antibiotic guidelines on suspected bacterial meningitis!

Authors:  Kordo Saeed; Timothy Stannard; Matthew Dryden; Helen Lambert
Journal:  Br J Gen Pract       Date:  2011-10       Impact factor: 5.386

Review 2.  Neuro-intensive care of patients with acute CNS infections.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Meningococcal meningitis.

Authors:  Ricardo G Branco; Robert C Tasker
Journal:  Curr Treat Options Neurol       Date:  2010-09       Impact factor: 3.598

4.  Josef Brudzinski and Vladimir Mikhailovich Kernig: signs for diagnosing meningitis.

Authors:  Michael A Ward; Tonia M Greenwood; David R Kumar; Joseph J Mazza; Steven H Yale
Journal:  Clin Med Res       Date:  2010-03

5.  Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates.

Authors:  Matthew R L Brown; Graeme Jones; Kathryn L Nash; Mark Wright; Indra Neil Guha
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 6.  [Appropriate microbiological diagnostics].

Authors:  A C Rodloff; R Schaumann; R Blatz
Journal:  Internist (Berl)       Date:  2006-02       Impact factor: 0.743

7.  Prognostic factors in adult community-acquired bacterial meningitis: a 4-year retrospective study.

Authors:  F A Dauchy; D Gruson; G Chêne; J Viot; C Bebear; J Maugein; M C Bézian; H Dutronc; M Dupon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

8.  Management of acute meningitis.

Authors:  Michael J Griffiths; Fiona McGill; Tom Solomon
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

Review 9.  [Bacterial infections of the central nervous system].

Authors:  M Klein; H-W Pfister
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

10.  Early antimicrobial therapy in severe sepsis and septic shock.

Authors:  Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.